Bristol Myers and Pfizer Join Mark Cuban Pharmacy

Patients can purchase the blood thinner Eliquis for three hundred forty five dollars starting April 27. The move expands direct buying options for consumers.

Xurve View
洞察:

Pharmaceutical giants BRISTOL-MYERS SQUIBB CO and PFIZER INC have announced a new partnership to offer their widely used blood thinner, Eliquis, through Mark Cuban's Cost Plus Drug Company. Starting April 27, patients with a valid prescription will be able to purchase a 30-day supply of the medication for $345 via the online pharmacy platform.

A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo
IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。